James Balmain - Induction Healthcare CEO Director
INHC Stock | 9.00 0.00 0.00% |
CEO
James Balmain is CEO Director of Induction Healthcare Group
Phone | 44 33 3939 8091 |
Web | https://www.inductionhealthcare.com |
Induction Healthcare Management Efficiency
The company has return on total asset (ROA) of (0.1021) % which means that it has lost $0.1021 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1691) %, meaning that it generated substantial loss on money invested by shareholders. Induction Healthcare's management efficiency ratios could be used to measure how well Induction Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 5 records | CEO Age | ||
Michael Rhodes | Ally Financial | 58 | |
Klaus Fiedler | LPKF Laser Electronics | 53 | |
Jeffrey Brown | Ally Financial | 51 | |
Holger Laubenthal | Cembra Money Bank | 52 | |
Brian Doubles | Synchrony Financial | 48 |
Management Performance
Return On Equity | -0.17 | |||
Return On Asset | -0.1 |
Induction Healthcare Leadership Team
Elected by the shareholders, the Induction Healthcare's board of directors comprises two types of representatives: Induction Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Induction. The board's role is to monitor Induction Healthcare's management team and ensure that shareholders' interests are well served. Induction Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Induction Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Guy Mitchell, Chief Officer | ||
Lloyd Price, Group Communications | ||
Alison Talbot, Sec | ||
Louise Torr, Company Secretary | ||
Ibraheem Mahmood, Chief Officer | ||
Andrew Williams, Chief Officer | ||
James Balmain, CEO Director | ||
CA CA, CFO Director | ||
Paul Tambeau, CEO Director |
Induction Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Induction Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.17 | |||
Return On Asset | -0.1 | |||
Profit Margin | (0.31) % | |||
Operating Margin | (0.62) % | |||
Current Valuation | 4.81 M | |||
Shares Outstanding | 93.85 M | |||
Shares Owned By Insiders | 53.78 % | |||
Shares Owned By Institutions | 45.02 % | |||
Price To Book | 0.46 X | |||
Price To Sales | 0.66 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Induction Stock Analysis
When running Induction Healthcare's price analysis, check to measure Induction Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Induction Healthcare is operating at the current time. Most of Induction Healthcare's value examination focuses on studying past and present price action to predict the probability of Induction Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Induction Healthcare's price. Additionally, you may evaluate how the addition of Induction Healthcare to your portfolios can decrease your overall portfolio volatility.